# A Clinical Study to Evaluate the Safety of VIB305 in Patients With Advanced Solid Tumors

Source: https://onco.cc/trials/nct07222969/  
OnCo record `nct07222969` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of VIB305 for Injection in advanced solid tumours, run by Vibrant Sciences Limited, now recruiting.

## Summary

A Clinical Study to Evaluate the Safety of VIB305 in Patients With Advanced Solid Tumors is a phase 1/2 interventional study registered as NCT07222969 by Vibrant Sciences Limited, with 146 participants planned, started 2026-01-12 and due to reach its primary completion in 2027-04-30. Interventions recorded: VIB305 for Injection.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT07222969
- Phase: 1/2
- Setting: An Open-label, Dose-escalation and Dose-expansion Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic (PK) Characteristics, and Preliminary Efficacy of VIB305 in Patients With Advanced Solid Tumors
- Sponsor: Vibrant Sciences Limited
- Enrolled: 146

## Sources

- ClinicalTrials.gov NCT07222969: https://clinicaltrials.gov/study/NCT07222969

## Connected records

- cancers: [Metastatic cancer (cancer that has spread)](https://onco.cc/cancers/metastatic-cancer/)

---
JSON: https://onco.cc/api/v1/entities/nct07222969.json